Type
1.
Shamsuzzaman, Haq R, Karim M, Azad M, Mahmood S, Khair A, et al. The significant scale up and success of Transmission Assessment Surveys ’TAS’ for endgame surveillance of lymphatic filariasis in Bangladesh: One step closer to the elimination goal of 2020. PLoS neglected tropical diseases [Internet]. 2017;11(1):e0005340. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0005340&type=printable
Type
1.
Ukpong, Davison Mbere-obong. Spatial distribution of lymphatic filariasis in Cross River state, Nigeria: a geographical information systems (gis) study. International Journal of Research - Granthaalayah [Internet]. 2016;4(12):101-9. Available from: http://granthaalayah.com/Articles/Vol4Iss12/13_IJRG16_C12_183.pdf
Type
1.
Cheuka PM, Mayoka G, Mutai P, Chibale K. The role of natural products in drug discovery and development against neglected tropical diseases. Molecules (Basel, Switzerland) [Internet]. 2016;22(1). Available from: http://www.mdpi.com/1420-3049/22/1/58/htm
Type
1.
Netto MJ, Bonfim C, Brandão E, Aguiar-Santos AM, Medeiros Z. Burden of lymphatic filariasis morbidity in an area of low endemicity in Brazil. Acta tropica. 2016;163:54-60.
Type
1.
Turner H, Bettis A, Chu B, McFarland D, Hooper P, Ottesen E, et al. The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014). Infectious diseases of poverty [Internet]. 2016;5(1):54. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937583/pdf/40249_2016_Article_147.pdf
Type
1.
Kastner, Stone, Steinmann, Tanner, Tediosi. Lessons learned from developing an eradication investment case for lymphatic filariasis. Advances in parasitology. 2016;94:393-417.
Type
1.
Albonico, Levecke, LoVerde, Montresor, Prichard, Vercruysse, et al. Monitoring the efficacy of drugs for neglected tropical diseases controlled by preventive chemotherapy. Journal of global antimicrobial resistance. 2015;3(4):229-36.
Type
1.
World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2015. Weekly epidemiological record [Internet]. 2016;91(39):441-60. Available from: http://apps.who.int/iris/bitstream/10665/250245/1/WER9139.pdf
Type
1.
Babu B, Babu G. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014;108(9):538-49.
Type
1.
Walsh V, Little K, Wiegand R, Rout J, Fox L. Evaluating the burden of lymphedema due to lymphatic filariasis in 2005 in Khurda District, Odisha State, India. PLoS neglected tropical diseases [Internet]. 2016;10(8):e0004917. Available from: http://journals.plos.org/plosntds/article/asset?id=10.1371%2Fjournal.pntd.0004917.PDF